×
A Double-Blind, Placebo-Controlled Trial of Extract of Ginkgo biloba Added to Haloperidol in Treatment-Resistant Patients With Schizophrenia PDF
$ 40.00
A Double-Blind, Placebo-Controlled Trial of Extract of Ginkgo biloba Added to Haloperidol in Treatment-Resistant Patients With Schizophrenia PDF quantity
$ 40.00
×
Risk Factors for Premenstrual Dysphoric Disorder in a Community Sample of Young Women: The Role of Traumatic Events and Posttraumatic Stress Disorder. PDF
$ 40.00
Risk Factors for Premenstrual Dysphoric Disorder in a Community Sample of Young Women: The Role of Traumatic Events and Posttraumatic Stress Disorder. PDF quantity
$ 40.00
×
Predicted Risk of Diabetes and Coronary Heart Disease in Patients With Schizophrenia: Aripiprazole Versus Standard of Care PDF
$ 40.00
Predicted Risk of Diabetes and Coronary Heart Disease in Patients With Schizophrenia: Aripiprazole Versus Standard of Care PDF quantity
$ 40.00
×
Transcranial Magnetic Stimulation in the Treatment of Major Depressive Disorder: A Comprehensive Summary of Safety Experience From Acute Exposure, Extended Exposure, and During Reintroduction Treatment PDF
$ 40.00
Transcranial Magnetic Stimulation in the Treatment of Major Depressive Disorder: A Comprehensive Summary of Safety Experience From Acute Exposure, Extended Exposure, and During Reintroduction Treatment PDF quantity
$ 40.00
×
The Use of Dispensary-Obtained Tetrahydrocannabinol as a Treatment for Neuropsychiatric Symptoms of Dementia PDF
$ 40.00
The Use of Dispensary-Obtained Tetrahydrocannabinol as a Treatment for Neuropsychiatric Symptoms of Dementia PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart